Advertisement

Citation tools

Picardi, M. et al "Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma." Blood Advances 3.9 (2019): 1546-1552. Web. 23 May. 2019.